Clinical and translational informatics company, Aridhia, has opened a new office in the Queen Elizabeth University Hospital, the largest acute hospital in Western Europe.
The new office is home to an expanding team with a focus on data and analytics innovations in biomedical research and precision medicine. It will be located in the University of Glasgow’s Clinical Innovation Zone in the hospital’s Teaching and Learning Centre alongside Stratified Medicine Scotland Innovation Centre (SMS-IC).
The hospital is also set to be the home to Scotland’s only precision medicine centre of excellence, an initiative from the UK Government’s Precision Medicine Catapult Programme, which aims to act as a hub for national and regional precision medicine activities within the UK-wide network.
The new office puts Aridhia in the heart of Scotland’s precision medicine activity and will enable closer collaborative working between the company, University and SMS-IC, with a focus on the development of data-driven, operational clinical services that will benefit patients within Scotland and further afield.
Chris Roche, CEO at Aridhia commented: “We are excited by the innovative and important work produced by the University and SMS-IC, and are pleased we are able to make our own valuable contribution in this field.
“Our new office puts us at the forefront of the precision medicine frontier, and it’s fulfilling to work alongside our peers in Scotland’s national hub for precision medicine, and collaborate so closely on life-changing projects.
“The work happening here in Glasgow, including projects focused on pancreatic cancer, COPD, multiple sclerosis and rheumatoid arthritis, will benefit millions of people around the world, finding better treatments for an array of medical conditions that are targeted to the individual’s needs, faster than ever before.
“We are delighted that our software platform service has made such a significant contribution to this work, and we look forward to continuing to assist these vital research projects, and others around the world, for many years to come.”
Aridhia has close links with the University of Glasgow outside of precision medicine research. Since 2013 the company has been part of the CHART-ADAPT project, an Innovate UK funded collaboration with NHS Greater Glasgow & Clyde, Philips Healthcare, and the university that aims to improve the outcome of patients with traumatic brain injuries using complex data analysis.